Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT

被引：6
|
作者：
Sun, Haimin [1 ]
Yan, Han [2 ]
Yan, Zeying [1 ]
Zhu, Yongmei [2 ]
Yang, Guang [2 ]
Zhang, Sujiang [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Hematol, Sch Med, Ruijin Rd 2 197, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, State Key Lab Med Gen, Natl Res Ctr Translat Med Shanghai, Shanghai Inst Hematol,Ruijin Hosp,Sch Med, Ruijin Rd 2 197, Shanghai, Shanghai, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / 02期
关键词：
NUP98/NSD1;
D O I：
10.1007/s00277-022-05047-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：473 / 475
页数：3
相关论文
共 21 条
  • [1] Acute myeloid leukemia patients with NUP98::NSD1 showing initially poor treatment response can benefit from FLT3 inhibitors and venetoclax as well as HSCT
    Haimin Sun
    Han Yan
    Zeying Yan
    Yongmei Zhu
    Guang Yang
    Sujiang Zhang
    Annals of Hematology, 2023, 102 : 473 - 475
  • [2] NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia
    Matsukawa, Toshihiro
    Yin, Mianmian
    Nigam, Nupur
    Negi, Vijay
    Li, Li
    Small, Donald
    Zhu, Yuelin J.
    Walker, Robert L.
    Meltzer, Paul S.
    Aplan, Peter D.
    LEUKEMIA, 2023, 37 (07) : 1545 - 1548
  • [3] NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia
    Toshihiro Matsukawa
    Mianmian Yin
    Nupur Nigam
    Vijay Negi
    Li Li
    Donald Small
    Yuelin J. Zhu
    Robert L. Walker
    Paul S. Meltzer
    Peter D. Aplan
    Leukemia, 2023, 37 : 1545 - 1548
  • [4] Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
    Mitani, Yuichi
    Hiwatari, Mitsuteru
    Seki, Masafumi
    Hangai, Mayumi
    Takita, Junko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (04) : 512 - 516
  • [5] Successful treatment of acute myeloid leukemia co-expressing NUP98/NSD1 and FLT3/ITD with preemptive donor lymphocyte infusions
    Yuichi Mitani
    Mitsuteru Hiwatari
    Masafumi Seki
    Mayumi Hangai
    Junko Takita
    International Journal of Hematology, 2019, 110 : 512 - 516
  • [6] Combined treatment with venetoclax, dasatinib, and FLT3 inhibitors for NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia: A pediatric case report
    Wen, Xiaojia
    Wu, Ying
    Huang, Pengli
    Zheng, Huyong
    PEDIATRIC BLOOD & CANCER, 2023, 70 (07)
  • [7] NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients
    Wang, Jing-wen
    Yu-Li, Xing-Ge
    Yang, Xing-Ge
    Xu, Lu-Hong
    BMC PEDIATRICS, 2024, 24 (01)
  • [8] NUP98/NSD1 Translocation Further Risk-Stratifies Patients With FLT3/ITD In Acute Myeloid Leukemia: A Report From Children's Oncology Group and SWOG
    Ostronoff, Fabiana
    Othus, Megan
    Gerbing, Robert B.
    Loken, Michael R.
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Lange, Beverly J.
    Petersdorf, Stephen
    Radich, Jerald
    Appelbaum, Frederick R.
    Gamis, Alan S.
    Alonzo, Todd A.
    Meshinchi, Soheil
    BLOOD, 2013, 122 (21)
  • [9] NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
    Hollink, Iris H. I. M.
    van den Heuvel-Eibrink, Marry M.
    Arentsen-Peters, Susan T. C. J. M.
    Pratcorona, Marta
    Abbas, Saman
    Kuipers, Jenny E.
    van Galen, Janneke F.
    Beverloo, H. Berna
    Sonneveld, Edwin
    Kaspers, Gert-Jan J. L.
    Trka, Jan
    Baruchel, Andre
    Zimmermann, Martin
    Creutzig, Ursula
    Reinhardt, Dirk
    Pieters, Rob
    Valk, Peter J. M.
    Zwaan, C. Michel
    BLOOD, 2011, 118 (13) : 3645 - 3656
  • [10] NUP98/NSD1 CHARACTERIZES A NOVEL POOR PROGNOSTIC GROUP IN ACUTE MYELOID LEUKEMIA WITH A DISTINCT HOX GENE EXPRESSION PATTERN
    Hollink, Iris
    van den Heuvel-Eibrink, Marry M.
    Arentsen-Peters, Susan T. C. J. M.
    Pratcorona, Marta
    Abbas, Saman
    Kuipers, Jenny E.
    van Galen, Janneke F.
    Beverloo, H. Berna
    Sonneveld, Edwin
    Kaspers, Gert-Jan J. L.
    Trka, Jan
    Baruchel, Andre
    Zimmermann, Martin
    Creutzig, Ursula
    Reinhardt, Dirk
    Pieters, Rob
    Valk, Peter J. M.
    Zwaan, C. Michel
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 737 - 737
123